For immediate release |
12 January 2011 |
Oxford BioMedica Plc
Notification of Major Interest in Shares
|
|||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Oxford BioMedica Plc |
||
2. Reason for notification (yes/no) |
|||
An acquisition or disposal of voting rights |
Yes |
||
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
||
An event changing the breakdown of voting rights |
|
||
Other (please specify): |
|
||
3. Full name of person(s) subject to notification obligation: |
JP Morgan Asset Management Holdings Inc.
|
||
4. Full name of shareholder(s) (if different from 3): |
JP Morgan Asset Management UK Limited
|
||
5. Date of transaction (and date on which the threshold is crossed or reached if different): |
10 January 2011 |
||
6. Date on which issuer notified: |
11 January 2011 |
||
7. Threshold(s) that is/are crossed or reached: |
5% upwards |
||
8: Notified Details |
|||||||
A: Voting rights attached to shares
|
|||||||
Class/type of shares If possible use ISIN code
|
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction
|
|||||
Number of shares
|
Number of voting rights
|
Number of shares
|
Number of voting rights |
Percentage of voting rights |
|||
Direct |
Indirect |
Direct |
Indirect |
||||
GB0006648157
|
N/a |
N/a |
|
|
83,733,144 |
|
8.86% |
B: Financial Instruments
|
||||
Resulting situation after the triggering transaction
|
||||
Type of financial instrument |
Expiration date |
Exercise/ conversion period/date |
No. of voting rights that may be acquired (if the instrument exercised/converted) |
Percentage of voting rights |
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
|
||||
Resulting situation after the triggering transaction
|
||||
Type of financial instrument |
Expiration date |
Exercise/ conversion period/date |
No. of voting rights that may be acquired (if the instrument exercised/converted) |
Percentage of voting rights |
|
|
|
|
|
Total (A+B+C)
|
|
Number of voting rights |
Percentage of voting rights |
83,733,144 |
8.86% |
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: |
JP Morgan Asset Management UK Limited 83,833,144 (8.86%) |
Proxy Voting: |
|
10. Name of proxy holder:
|
|
11. Number of voting rights proxy holder will cease to hold:
|
|
12. Date on which proxy holder will cease to hold voting rights:
|
|
13. Additional information:
|
. |
14 Contact name:
|
Andrew Wood |
15. Contact telephone name:
|
01865 783000 |